share_log

天津发展(00882)：力生制药认购本金金额合共2.1亿元的结构性存款

Tianjin Dev (00882): Tianjin Lisheng Pharmaceutical subscribes to a total principal amount of 210 million yuan of structured deposits.

Zhitong Finance ·  Jun 11 17:52

Tianjin Dev (00882) announced that on April 30, 2024, its indirectly held non-wholly-owned subsidiary Tianjin Lisheng Pharmaceutical and CBHB signed the first CBHB Wealth Management Agreement, subscribing to structured deposits with a principal amount of RMB 60 million.

On June 11, 2024, Tianjin Lisheng Pharmaceutical and CBHB signed the second CBHB Wealth Management Agreement, subscribing to structured deposits with a principal amount of RMB 150 million.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment